SCHEMBL21414381

SCHEMBL21414381

CCC(C)c1ccc(CN2CCC(CO)CC2)cn1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 3/20 0.47
▸ ACHE P22303 1/20 0.43
▸ KMT2A Q03164 3/20 0.41
▸ LTA4H P09960 5/20 0.40
▸ PTK2 Q05397 1/20 0.39
▸ FAAH O00519 1/20 0.38
▸ CHRM1 P11229 2/20 0.37
▸ MCHR1 Q99705 2/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ CACNA1I Q9P0X4 1/20 0.37
▸ ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20203465 0.88 HRH3 (0.50) HRH3ACHEKMT2ALTA4HPTK2
SCHEMBL21414349 0.82 ALDH1A1 (0.50) HRH3KMT2AMEN1ALDH1A1RAB9A
SCHEMBL21414369 0.82 CXCR4 (0.44) HRH3KMT2ACHRM1MEN1
SCHEMBL21414345 0.81 KMT2A (0.41) HRH3KMT2AFAAHMEN1ALDH1A1
SCHEMBL21414453 0.81 CHEK1 (0.41) HRH3ACHEKMT2ALTA4HMEN1
SCHEMBL21414378 0.81 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1RAB9AATM
SCHEMBL21414385 0.80 LMNA (0.46) HRH3KMT2AMEN1ALDH1A1RAB9A
SCHEMBL21414344 0.79 HRH3 (0.46) HRH3ACHEKMT2ALTA4HCHRM1
SCHEMBL20038328 0.79 HRH3 (0.48) HRH3ACHEKMT2ALTA4HCHRM1
SCHEMBL20037827 0.76 HRH3 (0.48) HRH3ACHEKMT2ALTA4HCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 — — EP disclosed
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 — — EP disclosed
Send feedback